Artelo Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Artelo Biosciences Inc.
- Former names
- Reactive Medical INC. Knight Knox Development Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Solana Beach
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ARTL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001621221
- EIN
- 33-1220924
Board of directors
-
Connie Matsui · DirectorSince 2023
-
Douglas Blayney · DirectorSince 2023
-
Gregory D. Gorgas · Director · Pres, CEO, CFO, Treas & SecrSince 2023
-
Gregory Reyes · DirectorSince 2023
-
Robert Martin Emanuele · DirectorSince 2023
-
Steven Kelly · DirectorSince 2023
-
Tamara A. Favorito · DirectorSince 2023
Chief executives
Gregory D. Gorgas
· Pres, CEO, CFO, Treas & Secr
Dates unknown
Director election results
Annual meeting of January 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
64.1%
-
66.3%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Connie Matsui
- via Connie Matsui
- via Tamara A. Favorito
- via Tamara A. Favorito
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.